We carried out this evaluation by using one additional hiPSC with the AD-causative mutation P117L in PSEN1 gene, one sporadic AD-iPSC with the ApoE ε4/ε4 polymorphism, and one more control hiPSC (iN2) (Table 1). The gene discussed is APOE; the disease is Alzheimer disease.